FDA Inspection 1020627 — Provimi North America, LLC

Provimi North America, LLC — FEI 1921541

The FDA completed an inspection of Provimi North America, LLC on Aug 7, 2017 in Fremont, NE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 7, 2017
Fiscal Year
2017
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Fremont, NE (United States)

Citations

IDCFRDescription
163821 CFR 225.42(b)(5)Elements of receipt record
174421 CFR 225.42(b)(6)Daily inventory record kept
179221 CFR 225.42(b)(7)Discrepancies
181121 CFR 225.58(b)(1)Three assays per year
182121 CFR 225.58(b)(1)First batch assay

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.